Claritev (NYSE:CTEV) reported quarterly losses of $(4.23) per share which missed the analyst consensus estimate of $(3.38) by 25.15 percent. This is a 128.65 percent decrease over losses of $(1.85) per share from the same period last year. The company reported quarterly sales of $245.959 million which beat the analyst consensus estimate of $235.806 million by 4.31 percent. This is a 6.71 percent increase over sales of $230.495 million the same period last year.